22,135,656

Vote Records

28,570

Companies

12,092

Funds

3,981

Managers

Home › Companies › Q32 BIO INC. › 2024-2025

Q32 BIO INC. 2024-2025 Proxy Voting Records

Name: Q32 BIO INC. 2024-2025 proxy voting records
Creator: proxyvotesnow.com
License: https://creativecommons.org/licenses/by/4.0/

At Q32 BIO INC.'s shareholder meeting held June 13, 2025, in the 2024-2025 proxy season, 83 asset managers reported how they voted in their SEC Form N-PX filings, covering 692 separate fund positions. Their filings are grouped here into 11 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on a non-binding, advisory basis, the compensation of our named executive officers; — Q32 BIO INC.'s filing reports the proposal as approved, with 93% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Q32 BIO INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 17, 2025.

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and Q32 BIO INC.’s Form 8-K, filed June 17, 2025 (Item 5.07 on EDGAR). Page generated November 8, 2026.

11Reported items
83Asset managers
692Fund votes
June 13, 2025Meeting date

Results at a glance

Meeting of June 13, 2025: 7 items on Q32 BIO INC.’s Form 8-K, filed June 17, 2025: 3 approved · 4 without a stated outcome.

Material dissent

None.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2024-2025 2025-2026

Explore Q32 BIO INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by Q32 BIO INC.

These tallies are Q32 BIO INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 17, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Q32 BIO INC. — official shareholder meeting results, meeting held June 13, 2025
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Support (of votes cast)	Reported outcome	Voting standard
Elect Director: David Grayzel, M.D.	7,990,255	--	--	58,381	1,606,772	99.2%	Not verified	—
Elect Director: Isaac Manke, Ph.D.	7,505,450	--	--	543,186	1,606,772	93%	Not verified	—
Elect Director: Diyong Xu	7,726,233	--	--	322,403	1,606,772	96%	Not verified	—
2. To approve an amendment to the Company's Restated Certificate of Incorporation, as amended, to limit the liability of certain officers as permitted by amendments to Delaware law" beginning on page 13 of the Company's definitive proxy statement filed with th	7,982,591	58,141	7,904	--	1,606,772	99.2%	Approved	—
3. Ratification of the Appointment of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2025	9,641,976	7,634	5,798	--	--	99.9%	Approved	—
4. Non-Binding, Advisory Vote on the Compensation of the Company's Named Executive Officers	7,445,998	594,526	8,112	--	1,606,772	93%	Approved	—
6. Approval of an Adjournment of the Annual Meeting to the Extent There are Insufficient Votes to Approve Proposal No. 2	7,878,272	166,768	3,596	--	1,606,772	98%	Not verified	—

Source: Q32 BIO INC., Form 8-K, filed with the SEC on June 17, 2025 — read the filing on EDGAR.

How asset managers voted at the Q32 BIO INC. 2024-2025 meeting

Each item below shows how the 83 asset managers that disclosed a Q32 BIO INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Q32 BIO INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To elect David Grayzel, M.D., Isaac Manke, Ph.D. and Diyong Xu as Class I directors to our Board…: David Grayzel, M.D.

No official matchDIRECTOR ELECTIONS

94% of fund votes cast · no official result

FOR

Details: description as filed, votes by 17 asset managers

Description as filed by funds: To elect David Grayzel, M.D., Isaac Manke, Ph.D. and Diyong Xu as Class I directors to our Board of Directors, each to serve until the 2028 Annual Meeting of stockholders and until his successor has been duly elected and qualified, or until his earlier death, resignation, or removal: David Grayzel, M.D.

The 17 asset managers below reported 176,393 for, 11,167 withheld. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 176,393WITHHOLD: 11,167

Largest asset managers voting on “To elect David Grayzel, M.D., Isaac Manke, Ph.D. and Diyong Xu as Class I directors to our Board of Directors,” at Q32 BIO INC., 2024-2025
Asset manager	For	Withheld	Vote
Vanguard	114,930	0	For
Fidelity	14,685	6,887	Mixed
Equitable	10,234	4,280	Mixed
Northern Trust	11,078	0	For
TIAA	8,646	0	For
Lincoln Financial	4,800	0	For
Pacific Life	3,889	0	For
AIG/SunAmerica	3,113	0	For
Nationwide	1,609	0	For
ProShares	1,609	0	For
Calvert	591	0	For
T. Rowe Price	449	0	For
State Street	309	0	For
Brinker Capital Destinations Trust	215	0	For
PENN SERIES FUNDS INC	100	0	For
Guggenheim	69	0	For
DWS	67	0	For

2. To elect David Grayzel, M.D., Isaac Manke, Ph.D. and Diyong Xu as Class I directors to our Board of…: Diyong Xu

No official matchDIRECTOR ELECTIONS

82% of fund votes cast · no official result

FORWITHHOLD

Details: description as filed, votes by 17 asset managers

The 17 asset managers below reported 154,442 for, 33,118 withheld. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 154,442WITHHOLD: 33,118

Largest asset managers voting on “To elect David Grayzel, M.D., Isaac Manke, Ph.D. and Diyong Xu as Class I directors to our Board of Directors,” at Q32 BIO INC., 2024-2025
Asset manager	For	Withheld	Vote
Vanguard	114,930	0	For
Fidelity	14,685	6,887	Mixed
Equitable	10,234	4,280	Mixed
Northern Trust	0	11,078	Withhold
TIAA	8,646	0	For
Lincoln Financial	0	4,800	Withhold
Pacific Life	3,889	0	For
AIG/SunAmerica	0	3,113	Withhold
Nationwide	1,609	0	For
ProShares	0	1,609	Withhold
Calvert	0	591	Withhold
T. Rowe Price	449	0	For
State Street	0	309	Withhold
Brinker Capital Destinations Trust	0	215	Withhold
PENN SERIES FUNDS INC	0	100	Withhold
Guggenheim	0	69	Withhold
DWS	0	67	Withhold

3. To elect David Grayzel, M.D., Isaac Manke, Ph.D. and Diyong Xu as Class I directors to our Board…: Isaac Manke, Ph.D.

No official matchDIRECTOR ELECTIONS

75% of fund votes cast · no official result

FORWITHHOLD

Details: description as filed, votes by 17 asset managers

The 17 asset managers below reported 140,078 for, 47,482 withheld. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 140,078WITHHOLD: 47,482

Largest asset managers voting on “To elect David Grayzel, M.D., Isaac Manke, Ph.D. and Diyong Xu as Class I directors to our Board of Directors,” at Q32 BIO INC., 2024-2025
Asset manager	For	Withheld	Vote
Vanguard	114,930	0	For
Fidelity	0	21,572	Withhold
Equitable	0	14,514	Withhold
Northern Trust	11,078	0	For
TIAA	8,646	0	For
Lincoln Financial	4,800	0	For
Pacific Life	0	3,889	Withhold
AIG/SunAmerica	0	3,113	Withhold
Nationwide	0	1,609	Withhold
ProShares	0	1,609	Withhold
Calvert	0	591	Withhold
T. Rowe Price	0	449	Withhold
State Street	309	0	For
Brinker Capital Destinations Trust	215	0	For
PENN SERIES FUNDS INC	100	0	For
Guggenheim	0	69	Withhold
DWS	0	67	Withhold

4. Elect Director: David Grayzel, M.D.

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 2 wordings of this item as funds reported it.

99.2% Majority: yes · of votes cast

FOR 99.2%

FOR: 7,990,255WITHHELD: 58,381

Details: description as filed, official tally, votes by 5 asset managers

Description as filed by funds: Election of Class I Director to serve until the 2028 Annual Meeting of stockholders and until his successor has been duly elected and qualified, or until his earlier death, resignation, or removal: David Grayzel, M.D.

Q32 BIO INC.’s own tally for this item (“Elect Director: David Grayzel, M.D.”): 7,990,255 for, 58,381 withheld, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.2% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 5 asset managers below reported 224,133 for.

FOR

FOR: 224,133

Largest asset managers voting on “Election of Class I Director to serve until the 2028 Annual Meeting of stockholders and until his successor ha” at Q32 BIO INC., 2024-2025
Asset manager	For	Vote
BlackRock	193,840	For
Charles Schwab	13,012	For
QUANTITATIVE MASTER SERIES LLC	10,957	For
Global X	3,551	For
Bridge Builder Trust	2,773	For

5. Elect Director: Diyong Xu

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 2 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%

FOR: 7,726,233WITHHELD: 322,403

Details: description as filed, official tally, votes by 5 asset managers

Q32 BIO INC.’s own tally for this item (“Elect Director: Diyong Xu”): 7,726,233 for, 322,403 withheld, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 5 asset managers below reported 224,133 for.

FOR

FOR: 224,133

Largest asset managers voting on “Election of Class I Director to serve until the 2028 Annual Meeting of stockholders and until his successor ha” at Q32 BIO INC., 2024-2025
Asset manager	For	Vote
BlackRock	193,840	For
Charles Schwab	13,012	For
QUANTITATIVE MASTER SERIES LLC	10,957	For
Global X	3,551	For
Bridge Builder Trust	2,773	For

6. Elect Director: Isaac Manke, Ph.D.

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 2 wordings of this item as funds reported it.

93% Majority: yes · of votes cast

FOR 93%

FOR: 7,505,450WITHHELD: 543,186

Details: description as filed, official tally, votes by 5 asset managers

Q32 BIO INC.’s own tally for this item (“Elect Director: Isaac Manke, Ph.D.”): 7,505,450 for, 543,186 withheld, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 93% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 5 asset managers below reported 16,563 for, 207,570 withheld.

WITHHOLD

FOR: 16,563WITHHOLD: 207,570

Largest asset managers voting on “Election of Class I Director to serve until the 2028 Annual Meeting of stockholders and until his successor ha” at Q32 BIO INC., 2024-2025
Asset manager	For	Withheld	Vote
BlackRock	0	193,840	Withhold
Charles Schwab	13,012	0	For
QUANTITATIVE MASTER SERIES LLC	0	10,957	Withhold
Global X	3,551	0	For
Bridge Builder Trust	0	2,773	Withhold

7. To approve an amendment to the Company's Restated Certificate of Incorporation, as amended, to limit the liability of…

Official resultCORPORATE GOVERNANCEReported outcome: Approved

Combines 2 wordings of this item as funds reported it.

99.2% Approved · of votes cast

FOR 99.2%

FOR: 7,982,591AGAINST: 58,141

Details: description as filed, official tally, votes by 22 asset managers

Description as filed by funds: To approve an amendment to our Restated Certificate of Incorporation, as amended, to limit the liability of certain officers as permitted by amendments to Delaware law;

Q32 BIO INC.’s own tally for this item (“2. To approve an amendment to the Company's Restated Certificate of Incorporation, as amended, to limit the liability of certain officers as permitted by amendments to Delaware law" beginning on page 13 of the Company's ”): 7,982,591 for, 58,141 against — passed, per its Form 8-K filed June 17, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal No. 2 – Approval of Amendment of the Company's Certificate of Incorporation to Limit the Liability of Certain Officers of the Company: The stockholders approved an amendment to the Certificate of Incorporation to include an officer exculpation provision that limits the liability of certain…”
Support: 99.2% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 22 asset managers below reported 408,142 for, 3,551 against.

FOR

FOR: 408,142AGAINST: 3,551

Largest asset managers voting on “To approve an amendment to our Restated Certificate of Incorporation, as amended, to limit the liability of ce” at Q32 BIO INC., 2024-2025
Asset manager	For	Against	Vote
BlackRock	193,840	0	For
Vanguard	114,930	0	For
Fidelity	21,572	0	For
Equitable	14,514	0	For
Charles Schwab	13,012	0	For
Northern Trust	11,078	0	For
QUANTITATIVE MASTER SERIES LLC	10,957	0	For
TIAA	8,646	0	For
Lincoln Financial	4,800	0	For
Pacific Life	3,889	0	For
Global X	0	3,551	Against
AIG/SunAmerica	3,113	0	For
Bridge Builder Trust	2,773	0	For
Nationwide	1,609	0	For
ProShares	1,609	0	For
Calvert	591	0	For
T. Rowe Price	449	0	For
State Street	309	0	For
Brinker Capital Destinations Trust	215	0	For
PENN SERIES FUNDS INC	100	0	For
Guggenheim	69	0	For
DWS	67	0	For

8. Approval of an Adjournment of the Annual Meeting to the Extent There are Insufficient Votes to Approve Proposal No. 2

Outcome not verifiedCORPORATE GOVERNANCEReported outcome: Not verified

Combines 2 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 7,878,272AGAINST: 166,768

Details: description as filed, official tally, votes by 22 asset managers

Description as filed by funds: To approve the adjournment of the Annual Meeting to the extent there are insufficient votes at the Annual Meeting to approve Proposal No. 2; and

Q32 BIO INC.’s own tally for this item (“6. Approval of an Adjournment of the Annual Meeting to the Extent There are Insufficient Votes to Approve Proposal No. 2”): 7,878,272 for, 166,768 against, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 22 asset managers below reported 389,257 for, 22,436 against.

FOR

FOR: 389,257AGAINST: 22,436

Largest asset managers voting on “To approve the adjournment of the Annual Meeting to the extent there are insufficient votes at the Annual Meet” at Q32 BIO INC., 2024-2025
Asset manager	For	Against	Vote
BlackRock	193,840	0	For
Vanguard	114,930	0	For
Fidelity	21,572	0	For
Equitable	14,514	0	For
Charles Schwab	0	13,012	Against
Northern Trust	11,078	0	For
QUANTITATIVE MASTER SERIES LLC	10,957	0	For
TIAA	8,646	0	For
Lincoln Financial	0	4,800	Against
Pacific Life	3,889	0	For
Global X	0	3,551	Against
AIG/SunAmerica	3,113	0	For
Bridge Builder Trust	2,773	0	For
Nationwide	1,609	0	For
ProShares	1,609	0	For
Calvert	591	0	For
T. Rowe Price	0	449	Against
State Street	0	309	Against
Brinker Capital Destinations Trust	0	215	Against
PENN SERIES FUNDS INC	0	100	Against
Guggenheim	69	0	For
DWS	67	0	For

9. Non-Binding, Advisory Vote on the Compensation of the Company's Named Executive Officers

Official result Fund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 8 wordings of this item as funds reported it.

93% Approved · of votes cast

FOR 93%

FOR: 7,445,998AGAINST: 594,526

Details: description as filed, official tally, votes by 83 asset managers

Description as filed by funds: To approve, on a non-binding, advisory basis, the compensation of our named executive officers;

Q32 BIO INC.’s own tally for this item (“4. Non-Binding, Advisory Vote on the Compensation of the Company's Named Executive Officers”): 7,445,998 for, 594,526 against — passed, per its Form 8-K filed June 17, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal No. 4 – Non-Binding, Advisory Vote on the Compensation of the Company's Named Executive Officers: The stockholders of the Company approved, on a non-binding, advisory basis, the compensation of the Company's named executive officers.”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports: 22 asset managers voting on “To approve, on a non-binding, advisory basis, the compensation of our named executive officers;” at Q32 BIO INC., 2024-2025
Asset manager	For	Against	Vote
BlackRock	0	193,840	Against
Vanguard	114,930	0	For
Fidelity	0	21,572	Against
Equitable	0	14,514	Against
Charles Schwab	0	13,012	Against
Northern Trust	11,078	0	For
QUANTITATIVE MASTER SERIES LLC	0	10,957	Against
TIAA	8,646	0	For
Lincoln Financial	4,800	0	For
Pacific Life	0	3,889	Against
Global X	0	3,551	Against
AIG/SunAmerica	0	3,113	Against
Bridge Builder Trust	0	2,773	Against
Nationwide	0	1,609	Against
ProShares	0	1,609	Against
Calvert	0	591	Against
T. Rowe Price	0	449	Against
State Street	309	0	For
Brinker Capital Destinations Trust	215	0	For
PENN SERIES FUNDS INC	100	0	For
Guggenheim	0	69	Against
DWS	0	67	Against

Fund voting reports, all 22 managers: 140,078 for, 271,615 against.

Institutional-manager reports: 68 asset managers voting on “To approve, on a non-binding, advisory basis, the compensation of our named executive officers;” at Q32 BIO INC., 2024-2025
Asset manager	For	Against	Vote
ORBIMED ADVISORS LLC	2,252,987	0	For
Carlyle Group Inc.	1,102,741	0	For
ARCH Venture Management, LLC	320,482	0	For
BlackRock	2,123	148,996	Against
State Street	104,046	291	For
Fidelity	0	34,919	Against
Northern Trust	33,682	0	For
AQR	0	22,164	Against
GEODE CAPITAL MANAGEMENT, LLC	0	15,877	Against
Charles Schwab	0	13,012	Against
MELLON INVESTMENTS Corp	0	12,119	Against
Nuveen	8,646	0	For
Rhumbline	0	4,276	Against
Affinity Asset Advisors, LLC	7,847	0	For
Vanguard	4,584	2,613	Mixed
MML INVESTORS SERVICES, LLC	7,193	0	For
AllianceBernstein	0	4,280	Against
Dimensional	0	4,127	Against
Ethic Inc.	0	2,924	Against
Invesco	0	2,817	Against
WASHINGTON STATE INVESTMENT BOARD	0	2,814	Against
JPMorgan	0	2,758	Against
Federated Hermes	0	2,482	Against
NEW YORK STATE COMMON RETIREMENT FUND	0	2,400	Against
T. Rowe Price	0	2,247	Against

Institutional-manager reports, all 68 managers: 3,846,328 for, 294,614 against, 4,276 1 year. Showing the 25 largest; every one is in the interactive database (link above).

10. To approve, on a non-binding, advisory basis, the preferred frequency of future advisory votes on compensation of our…

No official match Fund totals may overlapSECTION 14A SAY-ON-PAY VOTES

Combines 6 wordings of this item as funds reported it.

0.1% Fund and manager reports combined; may count the same shares twice · no official result

1 YEAR

Details: description as filed, votes by 79 asset managers

Description as filed by funds: To approve, on a non-binding, advisory basis, the preferred frequency of future advisory votes on compensation of our named executive officers;

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 22 asset managers voting on “To approve, on a non-binding, advisory basis, the preferred frequency of future advisory votes on compensation” at Q32 BIO INC., 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
BlackRock	0	0	0	0	--
Vanguard	0	0	0	0	--
Fidelity	0	0	0	0	--
Equitable	0	0	0	0	--
Charles Schwab	0	0	0	0	--
Northern Trust	0	0	0	0	--
QUANTITATIVE MASTER SERIES LLC	0	0	0	0	--
TIAA	0	0	0	0	--
Lincoln Financial	0	0	0	0	--
Pacific Life	0	0	0	0	--
Global X	0	0	0	0	--
AIG/SunAmerica	0	0	0	0	--
Bridge Builder Trust	0	0	0	0	--
Nationwide	0	0	0	0	--
ProShares	0	0	0	0	--
Calvert	0	0	0	0	--
T. Rowe Price	0	0	0	0	--
State Street	0	0	0	0	--
Brinker Capital Destinations Trust	0	0	0	0	--
PENN SERIES FUNDS INC	0	0	0	0	--
Guggenheim	0	0	0	0	--
DWS	0	0	0	0	--

Fund voting reports, all 22 managers: 411,693 1 year.

Institutional-manager reports: 64 asset managers voting on “To approve, on a non-binding, advisory basis, the preferred frequency of future advisory votes on compensation” at Q32 BIO INC., 2024-2025
Asset manager	Against	Vote
ORBIMED ADVISORS LLC	0	--
Carlyle Group Inc.	0	--
BlackRock	0	--
State Street	0	--
Fidelity	0	--
Northern Trust	0	--
AQR	0	--
GEODE CAPITAL MANAGEMENT, LLC	0	--
Charles Schwab	0	--
MELLON INVESTMENTS Corp	0	--
Nuveen	0	--
Rhumbline	4,276	Against
Affinity Asset Advisors, LLC	0	--
Vanguard	0	--
MML INVESTORS SERVICES, LLC	0	--
AllianceBernstein	0	--
Dimensional	0	--
Ethic Inc.	0	--
Invesco	0	--
Federated Hermes	0	--
NEW YORK STATE COMMON RETIREMENT FUND	0	--
T. Rowe Price	0	--
American Investment Services, Inc.	0	--
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM	0	--
COLDSTREAM CAPITAL MANAGEMENT INC	0	--

Institutional-manager reports, all 64 managers: 4 for, 4,276 against, 3,810,404 1 year, 4,410 3 year. Showing the 25 largest; every one is in the interactive database (link above).

11. Ratification of the Appointment of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm for…

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 2 wordings of this item as funds reported it.

99.9% Approved · of votes cast

FOR 99.9%

FOR: 9,641,976AGAINST: 7,634

Details: description as filed, official tally, votes by 22 asset managers

Description as filed by funds: To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025;

Q32 BIO INC.’s own tally for this item (“3. Ratification of the Appointment of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2025”): 9,641,976 for, 7,634 against — passed, per its Form 8-K filed June 17, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal No. 3 – Ratification of the Appointment of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2025: The stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting…”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 22 asset managers below reported 411,693 for.

FOR

FOR: 411,693

Largest asset managers voting on “To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fi” at Q32 BIO INC., 2024-2025
Asset manager	For	Vote
BlackRock	193,840	For
Vanguard	114,930	For
Fidelity	21,572	For
Equitable	14,514	For
Charles Schwab	13,012	For
Northern Trust	11,078	For
QUANTITATIVE MASTER SERIES LLC	10,957	For
TIAA	8,646	For
Lincoln Financial	4,800	For
Pacific Life	3,889	For
Global X	3,551	For
AIG/SunAmerica	3,113	For
Bridge Builder Trust	2,773	For
Nationwide	1,609	For
ProShares	1,609	For
Calvert	591	For
T. Rowe Price	449	For
State Street	309	For
Brinker Capital Destinations Trust	215	For
PENN SERIES FUNDS INC	100	For
Guggenheim	69	For
DWS	67	For

Largest Q32 BIO INC. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 12,197,615 shares outstanding at the time of that meeting.

Fund voting reports: top Q32 BIO INC. shareholders by shares voted on “To approve, on a non-binding, advisory basis, the compensation of our named executive officers;”, 2024-2025
#	Asset manager	% of shares outstanding
1	BlackRock	1.59%
2	Vanguard	0.94%
3	Fidelity	0.18%
4	Equitable	0.12%
5	Charles Schwab	0.11%
6	Northern Trust	0.09%
7	QUANTITATIVE MASTER SERIES LLC	0.09%
8	TIAA	0.07%
9	Lincoln Financial	0.04%
10	Pacific Life	0.03%

Institutional-manager reports: top Q32 BIO INC. shareholders by shares voted on “To approve, on a non-binding, advisory basis, the compensation of our named executive officers;”, 2024-2025
#	Asset manager	% of shares outstanding
1	ORBIMED ADVISORS LLC	18.47%
2	Carlyle Group Inc.	9.04%
3	ARCH Venture Management, LLC	2.63%
4	BlackRock	1.24%
5	State Street	0.86%
6	Fidelity	0.29%
7	Northern Trust	0.28%
8	AQR	0.18%
9	GEODE CAPITAL MANAGEMENT, LLC	0.13%
10	Charles Schwab	0.11%

Reported Q32 BIO INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

Q32 BIO INC. holdings and ownership disclosed for the 2024-2025 proxy season
Holder	% outstanding	Disclosure
ORBIMED ADVISORS LLC	—	13D
BVF PARTNERS L P/IL	—	13G
RA Capital Management, L.P.	—	13G
Sirenia Capital Management LP	—	13G
Opaleye Management Inc.	—	13G
Point72 Asset Management, L.P.	—	13G
Atlas Venture Fund X, L.P.	—	13D
BlackRock	—	13F
Vanguard Group	—	13F
Pfizer Inc. (IRS Identification No.: 13-5315170)	—	13G

Percentages above are of 12,197,615 shares outstanding, as reported by Q32 BIO INC. on its Form 10-Q dated May 1, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Q32 BIO INC.’s 10-Q dated May 1, 2025. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.

Q32 BIO INC. proxy season coverage: 2024-2025 (this page) · 2025-2026.

Cite this page

proxyvotesnow.com, “Q32 BIO (QTTB) 2025 Annual Meeting: Vote Results & How Funds Voted”, https://proxyvotesnow.com/company/q32-bio-inc/2025 (version of November 8, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.

Q32 BIO INC. 2024-2025 Proxy Voting Records

Results at a glance

Material dissent

Official 2024-2025 meeting results reported by Q32 BIO INC.

How asset managers voted at the Q32 BIO INC. 2024-2025 meeting

1. To elect David Grayzel, M.D., Isaac Manke, Ph.D. and Diyong Xu as Class I directors to our Board…: David Grayzel, M.D.

2. To elect David Grayzel, M.D., Isaac Manke, Ph.D. and Diyong Xu as Class I directors to our Board of…: Diyong Xu

3. To elect David Grayzel, M.D., Isaac Manke, Ph.D. and Diyong Xu as Class I directors to our Board…: Isaac Manke, Ph.D.

4. Elect Director: David Grayzel, M.D.

5. Elect Director: Diyong Xu

6. Elect Director: Isaac Manke, Ph.D.

7. To approve an amendment to the Company's Restated Certificate of Incorporation, as amended, to limit the liability of…

8. Approval of an Adjournment of the Annual Meeting to the Extent There are Insufficient Votes to Approve Proposal No. 2

9. Non-Binding, Advisory Vote on the Compensation of the Company's Named Executive Officers

10. To approve, on a non-binding, advisory basis, the preferred frequency of future advisory votes on compensation of our…

11. Ratification of the Appointment of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm for…

Largest Q32 BIO INC. shareholders voting in 2024-2025

Reported Q32 BIO INC. holdings and ownership

Related

About this page

Cite this page